Patent · US Active

Methods for improving inflammatory bowel disease diagnosis

US8715943B2 · kind B2 · utility

8Cited by
16References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateMay 6, 2014
Priority date
Expiry dateMar 15, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides methods and systems to predict and diagnose inflammatory bowel disease (IBD) and subtypes such as ulcerative colitis (UC) and Crohn's disease (CD) by detecting the presence, absence, level, and/or genotype of one or more sero-genetic-inflammation markers. Advantageously, with the present invention, it is possible to provide a diagnosis of IBD versus non-IBD, to rule out IBD that is inconclusive for CD and UC, and to differentiate between CD and UC with increased accuracy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.